Correlation Between Centessa Pharmaceuticals and Melar Acquisition

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Melar Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Melar Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Melar Acquisition Corp, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Melar Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Melar Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Melar Acquisition.

Diversification Opportunities for Centessa Pharmaceuticals and Melar Acquisition

-0.25

Correlation Coefficient

Centessa Pharmaceuticals  Melar Acquisition

Very good diversification

The 3 months correlation between Centessa and Melar is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Melar Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Melar Acquisition Corp and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Melar Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Melar Acquisition Corp has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Melar Acquisition go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Melar Acquisition

Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 38.59 times less return on investment than Melar Acquisition. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 27.81 times less risky than Melar Acquisition. It trades about 0.08 of its potential returns per unit of risk. Melar Acquisition Corp is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Melar Acquisition Corp on October 7, 2024 and sell it today you would earn a total of  11.00  from holding Melar Acquisition Corp or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	37.0%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  Melar Acquisition Corp

Centessa Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Melar Acquisition Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Melar Acquisition Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, Melar Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Centessa Pharmaceuticals and Melar Acquisition

The main advantage of trading using opposite Centessa Pharmaceuticals and Melar Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Melar Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Melar Acquisition will offset losses from the drop in Melar Acquisition's long position.

The idea behind Centessa Pharmaceuticals PLC and Melar Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.